Literature DB >> 21671458

Serotonin transporter binding after recovery from bulimia nervosa.

Rama Pichika1, Monte S Buchsbaum, Ursula Bailer, Carl Hoh, Alex Decastro, Bradley R Buchsbaum, Walter Kaye.   

Abstract

OBJECTIVE: Physiological and pharmacological studies indicate that altered brain serotonin (5-HT) activity could contribute to a susceptibility to develop appetitive and behavioral alterations that are characteristic of bulimia nervosa (BN).
METHOD: Eight individuals recovered from BN (REC BN) and eight healthy control women were scanned with [11C]DASB and positron emission tomography imaging of the 5-HT transporter (5-HTT). Logan graphical analysis was applied, and parametric binding potential (BP(nondisplaceable (ND)) ) images were generated. Voxel-by-voxel t-tests and a region of interest (ROI) analysis were conducted.
RESULTS: REC BN had significantly lower [11C]DASB BP(ND) in midbrain, superior and inferior cingulate and significantly higher [11C]DASB BP(ND) in anterior cingulate and superior temporal gyrus in the voxel-based analysis. ROI analysis indicated lower [11C]DASB BP(ND) in midbrain (p = .07), containing the dorsal raphe, in REC BN, consistent with our earlier studies. DISCUSSION: These preliminary findings of a small-scale study confirm and extend previous data suggesting that ill and recovered BN have altered 5-HTT measures, which potentially contribute to BN symptomatology and/or differential responses to medication.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21671458      PMCID: PMC3175264          DOI: 10.1002/eat.20944

Source DB:  PubMed          Journal:  Int J Eat Disord        ISSN: 0276-3478            Impact factor:   4.861


  33 in total

Review 1.  A review of graphical methods for tracer studies and strategies to reduce bias.

Authors:  Jean Logan
Journal:  Nucl Med Biol       Date:  2003-11       Impact factor: 2.408

2.  Altered serotonin 2A receptor activity in women who have recovered from bulimia nervosa.

Authors:  W H Kaye; G K Frank; C C Meltzer; J C Price; C W McConaha; P J Crossan; K L Klump; L Rhodes
Journal:  Am J Psychiatry       Date:  2001-07       Impact factor: 18.112

Review 3.  Psychopharmacologic treatment of bulimia nervosa.

Authors:  B T Walsh
Journal:  J Clin Psychiatry       Date:  1991-10       Impact factor: 4.384

4.  Factor analysis for extraction of blood time-activity curves in dynamic FDG-PET studies.

Authors:  H M Wu; C K Hoh; Y Choi; H R Schelbert; R A Hawkins; M E Phelps; S C Huang
Journal:  J Nucl Med       Date:  1995-09       Impact factor: 10.057

5.  Positron emission tomography quantification of [(11)C]-DASB binding to the human serotonin transporter: modeling strategies.

Authors:  N Ginovart; A A Wilson; J H Meyer; D Hussey; S Houle
Journal:  J Cereb Blood Flow Metab       Date:  2001-11       Impact factor: 6.200

6.  The Yale-Brown Obsessive Compulsive Scale. II. Validity.

Authors:  W K Goodman; L H Price; S A Rasmussen; C Mazure; P Delgado; G R Heninger; D S Charney
Journal:  Arch Gen Psychiatry       Date:  1989-11

7.  Comparative evaluation of serotonin transporter radioligands 11C-DASB and 11C-McN 5652 in healthy humans.

Authors:  W Gordon Frankle; Yiyun Huang; Dah-Ren Hwang; Peter S Talbot; Mark Slifstein; Ronald Van Heertum; Anissa Abi-Dargham; Marc Laruelle
Journal:  J Nucl Med       Date:  2004-04       Impact factor: 10.057

8.  Distribution volume ratios without blood sampling from graphical analysis of PET data.

Authors:  J Logan; J S Fowler; N D Volkow; G J Wang; Y S Ding; D L Alexoff
Journal:  J Cereb Blood Flow Metab       Date:  1996-09       Impact factor: 6.200

9.  Alterations in serotonin activity and psychiatric symptoms after recovery from bulimia nervosa.

Authors:  W H Kaye; C G Greeno; H Moss; J Fernstrom; M Fernstrom; L R Lilenfeld; T E Weltzin; J J Mann
Journal:  Arch Gen Psychiatry       Date:  1998-10

10.  The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability.

Authors:  W K Goodman; L H Price; S A Rasmussen; C Mazure; R L Fleischmann; C L Hill; G R Heninger; D S Charney
Journal:  Arch Gen Psychiatry       Date:  1989-11
View more
  6 in total

Review 1.  Current status of functional imaging in eating disorders.

Authors:  Guido K W Frank; Walter H Kaye
Journal:  Int J Eat Disord       Date:  2012-04-25       Impact factor: 4.861

2.  White matter integrity is reduced in bulimia nervosa.

Authors:  Lisa N Mettler; Megan E Shott; Tamara Pryor; Tony T Yang; Guido K W Frank
Journal:  Int J Eat Disord       Date:  2013-01-28       Impact factor: 4.861

Review 3.  Ovarian hormones and obesity.

Authors:  Brigitte Leeners; Nori Geary; Philippe N Tobler; Lori Asarian
Journal:  Hum Reprod Update       Date:  2017-05-01       Impact factor: 15.610

4.  Interaction between serotonin transporter and dopamine D2/D3 receptor radioligand measures is associated with harm avoidant symptoms in anorexia and bulimia nervosa.

Authors:  Ursula F Bailer; Guido K Frank; Julie C Price; Carolyn C Meltzer; Carl Becker; Chester A Mathis; Angela Wagner; Nicole C Barbarich-Marsteller; Cinnamon S Bloss; Karen Putnam; Nicholas J Schork; Anthony Gamst; Walter H Kaye
Journal:  Psychiatry Res       Date:  2012-11-13       Impact factor: 3.222

5.  Neuroimaging in eating disorders.

Authors:  Ignacio Jáuregui-Lobera
Journal:  Neuropsychiatr Dis Treat       Date:  2011-09-29       Impact factor: 2.570

Review 6.  Perplexities of treatment resistance in eating disorders.

Authors:  Katherine A Halmi
Journal:  BMC Psychiatry       Date:  2013-11-07       Impact factor: 3.630

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.